Gratis boekenweekgeschenk bij een bestelling boven de €17,50 (geldt alleen voor Nederlandstalige boeken)
, ,

Encyclopedia of Hereditary Cancer

A Desktop Reference

Specificaties
Gebonden, blz. | Engels
Elsevier Science | e druk, 2024
ISBN13: 9780443135750
Rubricering
Juridisch :
Elsevier Science e druk, 2024 9780443135750
€ 172,60
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

Encyclopedia of Hereditary Cancer: A Desktop Reference gives insights into this young and rapidly expanding field that combines oncology and genetics to achieve risk reduction, early detection, family risk management, and identification targeted treatments. While genetics and oncology are both well-developed knowledge areas, their combination in hereditary cancer yields an opportunity for new works that systemize knowledge for current researchers, practitioners, and students. The book exams 371 topics through the lens of hereditary cancer. There are no similar books that presents information in this manner.

This reference work contains a complete list of terms and definitions which can be easily reference by researchers and clinicians working in this field.

Specificaties

ISBN13:9780443135750
Taal:Engels
Bindwijze:Gebonden

Inhoudsopgave

<p>Activating Variant IMAGE CONCEPT include hemizygous<br>Allele<br>Allele frequency<br>Allelic disorder<br>Allelic dropout<br>Alteration/variant/ mutation<br>Alternate parentage<br>Alu repeats<br>Amino acid<br>Amplicon. Include tiling density<br>Amplification<br>Aneuploid<br>Angiomyolipoma<br>Ankyrin repeat<br>Anticipation<br>APOBEC<br>Aspirin<br>Autosomes<br>Autosomal dominant<br>Autosomal recessive<br>Basal cell carcinoma<br>Base excision repair<br>BAP1 tumor predisposition syndrome<br>Belzutifan<br>Biallelic<br>Biallelic/compound heterozygosity<br>Birt Hogg Dube syndrome<br>Blastomere<br>BRCA pathway<br>Breast carcinoma<br>Breast tissue density<br>Bromodomain<br>BRRS<br>Cancer risk factors<br>CanRisk estimator<br>Carcinoma of unknown primary<br>Carotid body tumor<br>Cascade testing<br>Catalytic RNA<br>cfDNA/ctDNA<br>Checkpoint inhibitor<br>CHIP/ACE<br>Chorionic villus sampling<br>Chromosomal changes<br>Chromosomal microarray<br>Chromosomes<br>Cis<br>Colorectal cancer<br>Communicating results<br>Compound heterozygote<br>Congenital hypertrophy of the retinal pigment epithelium<br>Consanguinity<br>Constitutional/germline/gonadal<br>Constitutional mismatch repair deficiency<br>Consultand<br>Contiguous gene deletion syndrome<br>Copy-neutral loss of heterozygosity<br>Copy number alteration<br>Cortical tuber<br>Cowden syndrome<br>CpG island methylator phenotype<br>CpG islands<br>Deamination<br>Deletion<br>Delphi process<br>De novo hereditary/de novo tumor<br>De novo variant<br>DICER1 syndrome<br>Differing interpretation from two testing companies<br>Digenic modifiers<br>Digenic inheritance<br>Diploid<br>DNA damage<br>DNA – mitochondrial<br>DNA – nuclear<br>DNA quality<br>DNA repair<br>DNA sequence alterations - endogenous metabolic damage causing abundant G:C>T:A transversions<br>DNA sequence alterations - cytosine deamination<br>DNA sequence alterations - endogenous metabolic damage<br>DNA sequence alterations – environmental<br>DNA sequence alterations – replication<br>Dominant negative<br>Double heterozygote<br>Double somatic<br>Double strand break<br>Driver mutation<br>Duplication<br>Duty to recontact with new information<br>Dysplastic gangliocytoma of the cerebellum<br>Embryonic lethal<br>Endoscopic ultrasound<br>Endometrial carcinoma<br>Endolymphatic sac tumor<br>Environmental influences<br>Epigenetics<br>Epimutation<br>Epimutations<br>Esophagoduodenoscopy<br>Estrogen<br>Everolimus<br>Exon<br>Exonuclease<br>Expression<br>Familial<br>Familial adenomatous polyposis<br>Familial atypical multiple mole melanoma syndrome<br>Familial isolated pituitary adenoma<br>Familial medullary thyroid cancer<br>Fanconi anemia<br>FDA label<br>Fidelity<br>First degree relative<br>Fluorescent in situ hybridization<br>Founder variants<br>Frameshift<br>Functional haploidy<br>Fusion<br>Gain of function<br>Gamete<br>Gastric adenocarcinoma and proximal polyposis of the stomach<br>Gastric cancer<br>Gastro-entero-pancreatic<br>Gene conversion<br>Gene conversion/reduction to homozygosity<br>Gene dosage<br>Genes<br>Genetic<br>Genetic modifiers<br>Genome-wide loss of heterozygosity<br>Genome sequencing/ES<br>Genomic<br>Germline<br>GINA<br>Glomus tumors<br>Gonadal mosaicism<br>Glycosylase<br>Gorlin syndrome<br>Hamartin<br>Hamartoma<br>Haploid<br>Haploinsufficiency vs spontaneous mutation, noncancer syndromic features<br>Hedgehog<br>Hemangioblastoma<br>Hemizygosity<br>Hereditary<br>Hereditary breast and ovarian cancer syndrome<br>Hereditary diffuse gastric cancer<br>Hereditary/familial<br>Hereditary leiomyoma and renal cell cancer syndrome<br>Hereditary papillary renal cell carcinoma<br>Hereditary paraganglioma/pheochromocytoma<br>Heterozygous<br>HGVS nomenclature<br>Histones<br>Holliday junction<br>Homologous recombination deficiency<br>Homologous repair defect<br>Homozygous<br>Hormonal influence<br>Hotspot<br>Human reference genome<br>Hypomorphic variant – amorphic allele<br>Hypoxia<br>Immunohistochemistry<br>Immunotherapy<br>Imprinting<br>Inactivating<br>Indel<br>In-frame<br>Intron<br>Insertions and deletions<br>Ionizing radiation<br>Isodisomy<br>Juvenile Polyposis of Infancy<br>Kindred<br>Lagging strand<br>Large alterations – amplification<br>Large alterations – deletion<br>Large alterations - Fusion/translocation<br>Leiomyoma<br>Lipoma<br>Li-Fraumeni syndrome<br>Leading strand<br>Likely pathogenic variant<br>Limitations of reports<br>Lhermitte-Duclos<br>Locus<br>LOH<br>Loss of function<br>Loss of heterozygosity<br>Low allele frequency (10% reporting)<br>Lumpectomy<br>Lymphangioleiomyomatosis<br>Lynch syndrome<br>Lyonization<br>Macrocephaly<br>Malignant peripheral nerve sheath tumor<br>Magnetic resonance cholangiopancreatography<br>Mastectomy<br>Maternal to zygotic transition<br>Medical sophistication<br>Medullary thyroid cancer<br>Meiosis<br>Melanoma<br>Methylation<br>Mesothelioma<br>Metanephrines<br>Microdeletion<br>MicroRNA<br>Microsatellite<br>Microsatellite instability<br>Minor allele fraction (10% reporting threshold) see also VAF<br>Misincorporation<br>Mismatch repair<br>Missense variant<br>Mitosis<br>Molecular complexity<br>Monogenic<br>Mosaic<br>Mosaicism<br>Mosaicism, low level<br>Multifocal micronodular pneumocyte hyperplasia<br>Multiple endocrine neoplasia type 1<br>Multiple endocrine neoplasia type 2<br>Mutation cluster region<br>mRNA alterations<br>Muir-Torre syndrome<br>Multigene panel<br>Mutation<br>Mutation signature<br>MUTYH polyposis<br>National Comprehensive Cancer Network<br>Neurofibromatosis type 1<br>Neurofibromatosis type 2<br>Nevoid basal cell carcinoma<br>Next generation sequencing<br>Nephrectomy<br>Neuroendocrine tumor<br>Neurofibroma<br>Noninvasive prenatal diagnosis<br>Nonsense mediated decay<br>Nonsense variant<br>Nucleotide excision repair<br>Null mutation<br>Olaparib<br>Oncogene<br>Open reading frame<br>Orthogonal technique<br>Ovarian cancer<br>Overexpression<br>Oxidative damage<br>Paired tumor-germline testing<br>Pancreas cancer<br>Pancreatitis<br>Paraganglioma<br>Parent-of-origin effect<br>PARP<br>Pathway<br>Passenger mutation<br>Pathogenic variant<br>PD-L1<br>Pedigree<br>Pembrolizumab<br>Penetrance and expressivity<br>Peutz-Jegher syndrome<br>Pharmacogenomics<br>Phenocopies<br>Pheochromocytoma<br>Pituitary adenoma predisposition syndrome<br>Plexiform neurofibroma<br>Polyadenylation<br>Poly ADP ribose polymerase<br>Polygenic<br>Polymerase<br>Polymerase proofreading polyposis syndrome<br>Polymorphism<br>Polyp<br>POT1-tumor predisposition syndrome<br>Population database<br>Preimplantation genetic diagnosis<br>Prevention<br>Premature termination codon<br>Proband<br>Proficient<br>Promoter<br>Prostate cancer<br>Prostate specific antigen<br>Protein alterations<br>Pseudogene<br>PTEN hamartoma tumor syndrome<br>Red flags<br>Reduction to homozygosity<br>Reference genome<br>Reference transcript<br>Reimbursement<br>Renal cell carcinoma<br>Replication slippage<br>Reportable variants<br>Residual Risk<br>RET<br>Retinoblastoma<br>Reversion mutant<br>Ribosomal alterations<br>Risk assessment<br>Risk factors<br>Risk reducing surgery<br>Rhabdomyoma<br>Rs<br>Schwannomatosis<br>Scoliosis<br>Second hit<br>Sentinel lymph node<br>Simplex case<br>Single-base substitutions<br>Single nucleotide polymorphism<br>Single strand break<br>SNP<br>Somatic/tumor<br>Somatic variant classification<br>Splicing<br>Sporadic<br>Standardized uptake value<br>Subclone<br>Subependymal giant cell astrocytoma<br>Subependymal nodule<br>Surveillance<br>Syndromic<br>Synonymous mutation<br>Synonymous/silent variants. Splicing<br>Synthetic lethal<br>Targeted therapy<br>Telomere<br>Testing guidelines – shortcomings<br>Testing implications – benefits<br>Thyroid cancer<br>Tissues to test<br>Translocation<br>Transvaginal ultrasound<br>Tricholemmoma<br>Triploid – RCC MET<br>Topoisomerase<br>Trans<br>Transition<br>Transversion<br>Tuberin<br>Tuberous sclerosis complex<br>Tumor mutation burden<br>Tumor percentage<br>Tumor suppressor gene (TSG)<br>Two-hit (Knudson)<br>Tyrer-Cuzick risk estimation<br>Tyrosine kinase<br>Ultraviolet radiation<br>Uniparental disomy (isodisomy and heterodisomy)<br>Untranslated regions<br>Upstream regulatory regions<br>Uracil misincorporation<br>Variant allele frequency (also MAF)<br>Variant classification<br>Variant of uncertain significance<br>Variant not detected<br>Variant of uncertain significance<br>Vestibular schwannoma<br>Vismodegib<br>Von Hippel Lindau Syndrome<br>Whole body MRI<br>Zygosity<br>8-oxoG<br>5’ untranslated region<br>3’ untranslated region</p>

Net verschenen

€ 172,60
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Encyclopedia of Hereditary Cancer